G. Viegi (Pisa, Italy), J. Soriano (Bunyola, Mallorca Illes Balear, Spain)
Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care
J. Feary, L. Rodrigues, C. Smith, R. Hubbard, J. Gibson (Nottingham, London, United Kingdom)
|  |
Environmental tobacco smoke (ETS): lifetime exposure related to respiratory health in never smoker Italian women
M. Simoni, L. Carrozzi, F. Pistelli, S. Baldacci, A. Angino, M. Borbotti, S. Maio, F. Di Pede, G. Viegi (Pisa, Palermo, Italy)
| |
Associations between passive smoking in childhood and COPD among adult smokers
A. Johannessen, T. M. Eagan, J. Hardie, P. Bakke (Bergen, Norway; La Jolla, United States Of America)
| |
Air travel habits in patients with COPD
A. Edvardsen, A. Akerø, T. M. L. Eagan, M. Ryg, J. A. Hardie, P. S. Bakke, O. H. Skjønsberg (Hakadal, Oslo, Bergen, Norway)
|  |
Atopy and work-related exposure as risk factors of COPD in a cross-sectional study of farmers
W. Eduard, N. Pearce, J. Douwes (Oslo, Norway; Wellington, New Zealand)
| |
Relative and attributable risks associated with COPD in the BOLD study sites
R. Hooper, BOLD Study Group (London, United Kingdom)
| |
Gender difference in the association of CRP and lung function decline. A longitudinal population-based study
I. S. Olafsdottir, T. Gislason, V. Gudnason, B. Benediktsdottir, I. Olafsson, T. Aspelund, B. Thjodleifsson, C. Janson (Uppsala, Sweden; Reykjavik, Iceland)
| |
Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the PLATINO study
M. Montes de Oca, C. Talamo, D. Moreno, R. Perez-Padilla, M. Lopez, A. Muiño, J. Jardim, G. Valdivia, J. Pertuze, R. Halbert, A. Menezes (Caracas, Venezuela; Mexico City, Mexico; Montevideo, Uruguay; Sao Paulo, Pelotas, Brazil; Santiago de Chile, Chile; Los Angeles, United States Of America)
| |
Diurnal variation of symptoms and impact on morning activities in severe COPD: a pan-European cross-sectional study
M. R. Partridge, M. Cazzola, R. Kessler, M. Miravitlles, C. Vogelmeier, D. Leynaud, J. Ostinelli (London, United Kingdom; Rome, Italy; Strasbourg, Rueil-Malmaison, France; Barcelona, Spain; Marburg, Germany)
| |
Influence of two novel mutations in surfactant protein-c on lung function and disease: resequencing of 760 individuals followed by genotyping of 48,000 individuals from the general population
M. Bækvad-Hansen, B. G. Nordestgaard, A. Tybjærg-Hansen, M. Dahl (Herlev, Copenhagen, Denmark)
| |
nos1 and nos2a genetic variants modify the association between smoking and FENO level in non-asthmatics from the EGEA study
E. Bouzigon, M. Bechet, F. Monier, M. Boussaha, N. Le Moual, R. Matran, P. Scheinmann, J. Bousquet, I. Pin, M. Lathrop, F. Kauffmann, F. Demenais, R. Nadif (Paris, Villejuif, Lille, Grenoble, Evry, France)
| |
Fluticasone propionate/salmeterol and risk of incident cataracts among COPD patients in the UK
D. P. Miller, K. J. Davis (RTP, United States Of America)
| |
Underweight defined as low BMI in COPD – results from population studies
B. Eriksson, E. Rönmark, A. Lindberg, B. Lundbäck (Luleå, Stockholm, Umeå, Sweden)
| |
Genetically elevated ace activity is not associated with ischaemic heart disease, hypertension, or physical activity in COPD
J. Lee, B. Grønne Nordestgaard, M. Dahl (Copenhagen, Denmark)
| |
A prospective study on COPD and risk of mortality five years later
A. M. Menezes, A. Muino, M. Lopez, R. Perez-Padilla, M. Montes de Oca, C. Talamo, J. Jardim, G. Valdivia, P. C. Hallal (Pelotas, Sao Paulo, Brazil; Montevideo, Uruguay; Mexico city, Mexico; Caracas, Venezuela; Santiago, Chile)
| |
The impact of dynamic lung hyperinflation on morbidity and mortality in patients with chronic obstructive pulmonary disease
E. Ozgur, S. Atis, C. Ozge, B. Tasdelen (Mersin, Turkey)
| |
Description of gold-defined COPD severity stages in UK primary care
R. Suruki, H. Muellerova, R. Baxter, K. Davis (RTP, United States Of America; Greenford, United Kingdom)
| |
High prevalence of undiagnosed COPD in patients with cardiovascular disease
J. B. Soriano, F. Rigo, D. Guerrero, A. Yáñez, J. Forteza, G. Frontera, B. Togores, A. Agustí (Bunyola, Palma de Mallorca, Barcelona, Spain)
| |
Respiratory effects of occupational exposures and smoking in tile factory workers
M. S. Jaakkola, P. Sripaiboonkij, J. J. K. Jaakkkola (Oulu, Finland; Birmingham, United Kingdom)
| |
Median and 5-year survival of patients with COPD stage IV – a Swedish prospective closed cohort study
N. Stenfors (Östersund, Sweden)
| |